Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Mark S. Ordan sold 33,000 shares of the firm’s stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $13.26, for a total transaction of $437,580.00. Following the completion of the sale, the director now owns 147,923 shares of […]
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Shirley A. Weis sold 17,993 shares of the business’s stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $13.55, for a total transaction of $243,805.15. Following the transaction, the director now directly owns 18,675 shares of the company’s […]
Pediatrix Medical Group (NYSE:MD – Get Rating) had its target price decreased by Truist Financial from $17.00 to $15.00 in a research report released on Tuesday morning, The Fly reports. A number of other research firms have also weighed in on MD. StockNews.com initiated coverage on Pediatrix Medical Group in a research note on Thursday, […]
Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) have earned an average rating of “Hold” from the eight research firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target […]
Pediatrix Medical Group (NYSE:MD – Get Rating) had its target price reduced by Mizuho from $17.00 to $15.00 in a research report report published on Wednesday morning, The Fly reports. MD has been the subject of a number of other reports. Credit Suisse Group reduced their price objective on shares of Pediatrix Medical Group from […]